Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gad Getz

Showing results (211-220 of 397) with videos related to

Pageof 40
Sort By:
Nature|August 10, 2022
Diverse mutational landscapes in human lymphocytesHeather E Machado, Emily Mitchell, Nina F Øbro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2023
Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair DeficiencyAnirban Das, Uri Tabori, Lauren C Sambira Nahum, et al.
Nature Cancer|January 7, 2021
Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myelomaOksana Zavidij, Nicholas J Haradhvala, Tarek H Mouhieddine, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 14, 2020
Subependymal giant cell astrocytomas are characterized by mTORC1 hyperactivation, a very low somatic mutation rate, and a unique gene expression profileKrinio Giannikou, Zachary Zhu, Jaegil Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2012
Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2Heidi Greulich, Bethany Kaplan, Philipp Mertins, et al.
Cancer Discovery|November 23, 2013
MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF/MEK inhibitionNikhil Wagle, Eliezer M Van Allen, Daniel J Treacy, et al.
JAMA Oncology|July 17, 2015
Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell CarcinomaEliezer M Van Allen, Vivian W Y Lui, Ann Marie Egloff, et al.
Science Translational Medicine|September 17, 2020
Distinct evolutionary paths in chronic lymphocytic leukemia during resistance to the graft-versus-leukemia effectPavan Bachireddy, Christina Ennis, Vinhkhang N Nguyen, et al.
The New England Journal of Medicine|December 14, 2011
SF3B1 and other novel cancer genes in chronic lymphocytic leukemiaLili Wang, Michael S Lawrence, Youzhong Wan, et al.
Blood Advances|February 10, 2025
Single-cell dynamics of breakthrough toxicities after anakinra prophylaxis for axicabtagene ciloleucel in lymphomaMatthew J Frigault, Ning Yao, Trisha R Berger, et al.
Pageof 40

Showing results (211-220 of 397) with videos related to

Sort By:
Pageof 40
Nature|August 10, 2022
Diverse mutational landscapes in human lymphocytesHeather E Machado, Emily Mitchell, Nina F Øbro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2023
Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair DeficiencyAnirban Das, Uri Tabori, Lauren C Sambira Nahum, et al.
Nature Cancer|January 7, 2021
Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myelomaOksana Zavidij, Nicholas J Haradhvala, Tarek H Mouhieddine, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 14, 2020
Subependymal giant cell astrocytomas are characterized by mTORC1 hyperactivation, a very low somatic mutation rate, and a unique gene expression profileKrinio Giannikou, Zachary Zhu, Jaegil Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2012
Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2Heidi Greulich, Bethany Kaplan, Philipp Mertins, et al.
Cancer Discovery|November 23, 2013
MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF/MEK inhibitionNikhil Wagle, Eliezer M Van Allen, Daniel J Treacy, et al.
JAMA Oncology|July 17, 2015
Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell CarcinomaEliezer M Van Allen, Vivian W Y Lui, Ann Marie Egloff, et al.
Science Translational Medicine|September 17, 2020
Distinct evolutionary paths in chronic lymphocytic leukemia during resistance to the graft-versus-leukemia effectPavan Bachireddy, Christina Ennis, Vinhkhang N Nguyen, et al.
The New England Journal of Medicine|December 14, 2011
SF3B1 and other novel cancer genes in chronic lymphocytic leukemiaLili Wang, Michael S Lawrence, Youzhong Wan, et al.
Blood Advances|February 10, 2025
Single-cell dynamics of breakthrough toxicities after anakinra prophylaxis for axicabtagene ciloleucel in lymphomaMatthew J Frigault, Ning Yao, Trisha R Berger, et al.
Pageof 40